A Study of LJPC-501 in Pediatric Patients With Hypotension

Clinical trial NCT03431077 · COMPLETED

Trial details

NCT number: NCT03431077
Sponsor: La Jolla Pharmaceutical Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Catecholamine-resistant Hypotension (CRH)Distributive Shock High Output Shock Sepsis

Start date: 2018-02-11
Primary completion: 2018-04-14
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.